Is NovaBay Pharmaceuticals, Inc. (NBY) Stock Worth a Buy Friday?

NovaBay Pharmaceuticals, Inc. (NBY) stock is down -82.81% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NBY stock a score of 29 out of a possible 100.

That rank is influenced by a long-term technical score of 0. NBY's rank also includes a short-term technical score of 21.

NBY has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on NBY!

See Full NBY Report

What's Happening with NBY Stock Today

NovaBay Pharmaceuticals, Inc. (NBY) stock is unmoved -0.18% while the S&P 500 has gained 0.01% as of 1:05 PM on Friday, Sep 30. NBY is unmoved $0.00 from the previous closing price of $0.11 on volume of 774,340 shares. Over the past year the S&P 500 is lower by -15.47% while NBY is down -82.81%. NBY lost -$0.11 per share in the over the last 12 months. Click Here to get the full Stock Report for NovaBay Pharmaceuticals, Inc. stock.